查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830486

臍帶血銀行市場（按銀行模式、產品、應用和最終用戶分類）—2025-2032 年全球預測

Umbilical Cord Blood Banking Market by Banking Model, Offerings, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年臍帶血庫市場規模將成長 1,184.4 億美元，複合年成長率為 17.28%。

主要市場統計數據
基準年2024年 330.8億美元
預計2025年 389.2億美元
預測年份：2032年 1184.4億美元
複合年成長率（%） 17.28%

全面說明臍帶血庫的不斷發展，重點在於影響策略決策的臨床前景、營運要求和監管環境

臍帶血庫領域正處於臨床前景、技術創新和不斷變化的監管預期的十字路口。細胞處理和冷凍保存技術的進步重新激發了臨床醫生、研究人員和準父母的興趣，而不斷擴展的治療應用也促使行業和監管機構之間進行更深入的對話。因此，相關人員目前正在探索一個將長期生物資產儲存與短期轉化科學結合的格局。

實際上，銀行模式和服務產品反映了不同的價值提案。私人銀行專注於自體移植並單獨儲存以供家庭使用，而公共銀行則專注於用於移植和研究的異體移植。同時，實驗室自動化、品管和生存評估的改進降低了操作差異性，並提高了不同供應商之間的一致性。法律規範繼續塑造可接受的活動和商業化路徑，而將臨床證據生成與強大的品質系統相結合的組織正在獲得差異化的信譽。

本引言概述了以下核心動態：生態系統範圍內的結構性轉變、貿易行動帶來的政策壓力、特定領域的促進因素，以及為那些必須將科學機會轉化為可信賴、合規動態的領導者提供的實用建議。本書的其餘部分將以此為視角，概述中短期內對策略選擇影響最大的力量。

科學進步、營運標準化和不斷發展的臨床夥伴關係如何重塑整個產業的競爭重點和品質期望

在科學進步、處理技術改進以及相關人員期望轉變的推動下，臍帶血庫格局正在發生重大變化。再生醫學和細胞療法的突破正在拓展臍帶血儲存的臨床應用，促使現有臍帶血庫和新進者重新思考其服務模式並重視溝通。同時，自動化和標準化的活力測試正在提高看護者和研究人員目前期望的基線質量，將競爭從價格轉向臨床效用的展示。

此外，銀行機構與生技公司之間的夥伴關係正在加速轉化途徑。此類合作促進了對支持免疫療法和再生醫學等新型應用通訊協定的共同投資。同時，付款人和醫療保健系統開始評估長期療效，這將影響報銷情況和患者需求。監管機構也在調整其監管框架，以適應新興細胞療法，並制定新的合規要求，這需要製定積極主動的品質和文件策略。

綜合來看，這些因素正在重塑整個產業的戰略重點。那些投資於證據生成、加強可追溯性和低溫運輸管治、並建立臨床夥伴關係關係的組織將更有能力應對這項轉型。

評估2025年貿易政策調整和關稅如何改變該產業的採購、供應鏈彈性和合作研究策略

美國2025年貿易政策措施和關稅調整的實施，為活躍於支持臍帶血庫的全球供應鏈中的組織帶來了一系列新的營運和策略壓力。專用超低溫冷凍庫、實驗室耗材和試劑的採購通常依賴跨境供應商，而關稅導致的投入成本增加，使得籌資策略必須立即重新評估。這促使許多相關人員加速供應商多元化，並加強了關於近岸外包關鍵製造產能的討論。

除了採購之外，關稅也影響了合作研究安排。跨國臨床合作和試劑共用需要明確的合約條款來管理成本波動。研究機構已採取措施，修改合約風險分配，並為時間敏感型試劑建立庫存緩衝。此外，成本透明度的提高也促進了資源利用的創新，包括最佳化儲存安排和改進減量技術，以減少每個檢體的耗材消費量。

從策略角度來看，關稅環境促使人們更加重視供應鏈的透明度和韌性。先前在供應商資格確認和緊急時應對計畫方面投入不足的組織已經重新評估了這些優先事項。相反，那些利用戰略採購、長期供應商協議以及對國內產能進行增量投資的組織，最大限度地減少了中斷，並保持了臨床和研究活動的連續性。

深度細分分析揭示了銀行模式、服務產品、臨床應用和最終用戶期望的明確需求，這些需求推動了策略差異化

從銀行模式的角度評估市場，我們發現專注於個人託管服務的供應商與專注於公共服務及移植支援的供應商之間存在著明顯的差異。私人銀行傾向於投資與消費者教育、長期客戶維繫和家庭服務相關的價值提案，而公共銀行則優先考慮捐贈者招募、配對系統以及與國家移植網路的整合。

即確保出生時無菌且及時恢復的採集流程，包括細胞分離、活力檢測和用於冷凍保存的減容處理能力，用於移植或研究的臨床調度放行程序，以及在嚴格的可追溯性和溫度控制下保持樣本完整性的長期儲存系統。這些階段的創新可能會對下游效用和成本結構產生重大影響。

基於應用的細分突出了臨床和科研重點。貧血、白血病和淋巴瘤等血液疾病仍然是臍帶血移植的核心治療目標，而免疫和代謝疾病仍是研究的重點。再生醫學和研究應用拓展了儲存臍帶血的潛在效用，但需要進一步的療效和長期療效數據來支持其更廣泛的應用。

最後，診斷實驗室、醫院、診所和研究機構等終端使用者與資料庫的合作時間表和品質期望各不相同。另一方面，醫院和診所要求在數據採集和無縫臨床整合方面實現卓越的營運。研究機構則優先考慮可訪問性和標準化元資料，以實現可重複的研究。了解這些細分市場中細微的需求，有助於制定個人化的服務設計和合約結構。

美洲、中東和非洲以及亞太地區的區域動態和監管細微差別決定了投資重點和戰略夥伴關係

區域動態對法律規範、付款人態度以及臍帶血庫生態系統的成熟度有著強大的影響。在美洲，成熟的私人銀行網路與公共登記機構並存，臨床中心擁有豐富的移植經驗，支持高品質臍帶血庫的持續需求。區域監管機構正在逐步更新其指導方針，以適應細胞療法，營利性公司通常強調消費者參與度和產品差異化。

監管協調工作和國家組織授權塑造了歐洲、中東和非洲地區的營運要求。公共銀行基礎設施和國家登記系統在某些國家發揮關鍵作用，而跨國合作則支持移植配對。不同國家和地區的監管差異要求銀行投資跨境合規計畫和本地臨床夥伴關係關係，以確保服務多樣化的病患群體。

在亞太地區，新型治療方法的快速應用以及對生物技術基礎設施的投資正在推動對私人和公共銀行業務的需求。臨床試驗和轉化研究的發展為銀行與藥物開發商之間的合作模式創造了機會。然而，由於監管成熟度和報銷環境的差異，區域策略需要兼顧文化、臨床和政策差異。這些區域差異將決定基礎設施、臨床推廣和合規能力的投資重點。

競爭格局評估：展示聯盟、技術差異化和整合如何重新定義公司的策略和價值創造路徑

臍帶血庫產業的競爭態勢體現了傳統臍血庫、垂直整合的臨床服務機構以及致力於商業化新型處理和分析技術的敏捷新興企業的混合。現有臍血庫通常利用其採集網路、客戶關係和規模優勢進行長期儲存營運，而新進業者則通常專注於差異化的檢測能力、專有的可行性檢測法或與療法開發商的合作。

隨著研發人員為其臨床計畫尋求可靠、高品質的原料，生物庫與生技公司之間的策略聯盟正變得越來越普遍。這些聯盟通常包括對處理方案、驗證研究和資料共用協議的聯合投資，以加快轉換進度。同樣，提供自動化處理平台和先進低溫處理硬體的技術供應商也為生物庫創造了提高品質標準和降低單位差異的機會。

併購持續影響競爭格局，整合不僅能夠在儲存和合規方面實現規模經濟，還能推動臨床和研究服務的整合。同時，機構投資者和醫療保健系統正在探索合資專屬式和專屬銀行解決方案，以確保其內部治療產品線能夠獲得合格的捐贈者材料。總而言之，這些企業級策略反映出一個市場，在這個市場中，差異化越來越依賴證據產生、供應鏈可靠性以及支持臨床開發合作夥伴的能力。

領導者可操作的策略重點是臨床證據產生、營運彈性、策略夥伴關係和客戶參與，以確保長期價值

產業領導者應優先考慮平衡的方法，在增強臨床可信度的同時建立營運韌性。首先，透過前瞻性註冊和臨床醫生夥伴關係，投資於證據生成，以證明在目標適應症中的臨床效用。同時，將這些努力與強大的品質系統和透明的文件相結合，以促進與監管機構的互動，並支持與付款方的對話。

第二，透過多元化關鍵設備和耗材供應商、盡可能簽訂多年合約以及探索區域製造地和採購地點來增強供應鏈彈性，以緩解關稅相關的波動。同時，採用實驗室自動化和標準化可行性測試，以減少操作差異，並提高轉換專案中的單元效用。

第三，與治療開發公司和研究機構建立策略聯盟。共同開發契約和材料獲取安排可以創造新的收益來源，並加速臍帶血衍生應用的臨床檢驗。最後，透過數位入口網站增強面向客戶的能力，從而實現更清晰的教育、儲存後的互動、簡化的長期儲存決策以及生命週期收益機會。結合這些行動，將使組織能夠抓住臨床機遇，同時管理監管和商業風險。

一個強大的混合方法研究框架，結合專家訪談、監管機構審查和數據三角測量來支持基於證據的策略建議

本研究整合了主要相關人員訪談、監管和臨床文獻綜述以及對工作實踐的觀察性分析，以得出基於證據的結論。主要相關人員訪談包括與實驗室主任、移植臨床醫生、採購專業人員和監管專家進行結構化對話，以了解現實世界的挑戰和不斷變化的期望。此外，我們也仔細查閱了指導文件、臨床試驗註冊中心以及記錄操作創新和治療結果的同行評審研究，以補充這些訪談。

二次研究整合了行業出版物、技術供應商規範和公開的政策更新，以便將營運趨勢置於更廣泛的貿易和監管格局中。資料三角檢驗確保了不同資訊來源的一致性，並將差異性結果與後續研究或其他資料管道進行交叉檢驗。品質保證流程包括專家同儕審查和情境分析，以確定對政策變化和技術採用曲線的合理應對措施。

調查方法著重於定性深度而非推測性的定量預測，使讀者能夠理解將科學可能性轉化為可靠服務所需的因果關係、操作手段和實際步驟。為了支持自信的決策，我們對所有關鍵聲明（包括來源歸屬和調查方法限制）保持透明。

結論：品質、策略夥伴關係和供應鏈彈性將決定哪些組織引領下一階段的治療和臨床應用

科學進步、運作標準化和地緣政治壓力的交匯，正在深刻重塑臍帶血庫生態系統。如今，臨床機會與對可追溯性、品質和協作證據生成日益成長的期望並存。同時，供應鏈中斷和關稅趨勢凸顯了採購敏捷性和本地能力建構的重要性。

將實驗室卓越性與積極主動的監管參與和策略夥伴關係相結合的組織將獲得競爭優勢。對經過驗證的處理通訊協定、自動化可行性測試和持續的臨床關係的投資，為長期的相關性奠定了基礎。相反，那些在整合新技術方面進展緩慢或未能增強供應鏈韌性的公司，則可能面臨營運中斷和臨床可靠性下降的風險。

最後，那些將臍帶血庫不僅僅視為一項儲存服務，更視為轉化科學重要合作夥伴的營運商將在該產業的發展軌跡中受到青睞。透過強調品質、協作和適應性，領導者可以在保護儲存生物資產完整性的同時，開拓更廣泛的臨床應用。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大採用先進的冷凍保存技術來提高儲存臍帶血幹細胞的活力和壽命
  • 推動人工智慧與區塊鏈的整合，提高臍帶血儲存和使用的可追溯性和透明度
  • 個人化醫療的出現推動了針對性免疫治療的 HLA 型臍帶血單位的需求
  • 擴大公私混合臍帶血庫，改善新興國家的可及性
  • 增加臍帶血造血幹細胞體外擴增研究的投入，以擴大其臨床應用範圍
  • 協調監管工作，制定臍帶血庫服務品質和安全的國際標準
  • 生技公司和臍帶血庫合作利用新生兒幹細胞商業化新型細胞治療產品
  • 以消費者為中心的行銷宣傳活動，強調自體臍帶血庫的未來治療潛力
  • 採用微創採集套件，方便孕婦在家採集臍帶血
  • 推出經濟高效的模組化儲存解決方案，以降低臍帶血庫的營運費用

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 臍帶血銀行市場（依銀行模式）

  • 私人的
  • 公共

9. 臍帶血庫市場（依產品類型）

  • 收藏
  • 流程
    • 細胞分離
    • 能源測試
    • 體積縮減
  • 發布
  • 貯存

第 10 章臍帶血庫市場（依應用）

  • 血液疾病
    • 貧血
    • 白血病
    • 淋巴瘤
  • 免疫疾病
  • 代謝紊亂
  • 再生醫學
  • 調查

第 11 章臍帶血庫市場（依最終用戶分類）

  • 診斷實驗室
  • 醫院和診所
  • 研究機構

第 12 章。按地區分類的臍帶血庫市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章臍帶血庫市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國臍帶血庫市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Cord Blood Registry, LLC
    • Cryo-Cell International, Inc.
    • ViaCord, LLC
    • StemCyte, Inc.
    • Macopharma SA
    • Stemlife Berhad
    • Cell Care Pty Ltd
    • LifeCell International Private Limited
    • Smart Cells International
    • ViaCord
Product Code: MRR-430D5F382283

The Umbilical Cord Blood Banking Market is projected to grow by USD 118.44 billion at a CAGR of 17.28% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 33.08 billion
Estimated Year [2025] USD 38.92 billion
Forecast Year [2032] USD 118.44 billion
CAGR (%) 17.28%

Comprehensive orientation to the evolving cord blood banking landscape highlighting clinical promise, operational imperatives, and regulatory dynamics shaping strategic decisions

The umbilical cord blood banking field stands at the intersection of clinical promise, technological innovation, and evolving regulatory expectations. Advances in cell processing and cryopreservation have catalyzed renewed interest among clinicians, researchers, and prospective parents, while expanding therapeutic applications are driving deeper conversations between industry and regulators. As a result, stakeholders now navigate a landscape that blends long-term custody of biological assets with near-term translational science.

In practice, banking models and service offerings reflect distinct value propositions. Private banks emphasize individualized storage for potential autologous or family-directed use, while public banks focus on allogeneic availability for transplantation and research. Concurrently, improvements in laboratory automation, quality control, and viability assessment have compressed operational variances, enabling higher consistency across providers. Regulatory frameworks continue to shape permissible activities and commercialization pathways, and organizations that align clinical evidence generation with robust quality systems gain differentiated credibility.

This introduction frames the core dynamics that follow: structural shifts across the ecosystem, policy pressures from trade measures, segmentation-specific drivers, and practical recommendations for leaders who must translate scientific opportunity into reliable, compliant services. Through this lens, the remainder of the document outlines the forces that will most influence strategic choices over the near to medium term.

How scientific advances, operational standardization, and evolving clinical partnerships are reshaping competitive priorities and quality expectations across the industry

The landscape of cord blood banking is undergoing transformative shifts driven by converging scientific advances, improvements in processing technologies, and changing stakeholder expectations. Breakthroughs in regenerative medicine and cell therapy have expanded the clinical rationale for preserving cord blood, prompting both established banks and new entrants to revisit service models and value communications. At the same time, automation and standardized viability testing have raised the baseline quality that caregivers and researchers now expect, shifting competition away from price toward demonstrated clinical utility.

Moreover, partnerships between banking organizations and biotechnology firms are accelerating translational pathways. These collaborations foster shared investment in protocols that support novel applications, including immunotherapies and regenerative indications. Concurrently, payers and health systems are beginning to evaluate long-term outcomes, which will influence reimbursement conversations and patient demand. Regulatory bodies are also adapting oversight frameworks to accommodate emerging cell-based therapies, creating new compliance requirements that necessitate proactive quality and documentation strategies.

Taken together, these factors are reshaping strategic priorities across the sector. Organizations that invest in evidence generation, strengthen traceability and cold chain governance, and cultivate clinical partnerships will navigate the transition more successfully, while those that delay integration of new technologies and regulatory alignment may face competitive and compliance risks.

Assessment of how 2025 trade policy adjustments and tariffs reshaped procurement, supply chain resilience, and collaborative research strategies within the sector

The introduction of trade policy measures and tariff adjustments by the United States in 2025 introduced a new set of operational and strategic pressures for organizations active in global supply chains supporting cord blood banking. Sourcing of specialized cryogenic freezers, laboratory consumables, and reagents often relies on cross-border suppliers, and tariff-driven input cost increases necessitated immediate reassessment of procurement strategies. In response, many stakeholders accelerated supplier diversification and intensified conversations about nearshoring of critical manufacturing capacity.

Beyond procurement, tariffs influenced collaborative research arrangements. Cross-border clinical collaborations and reagent sharing require clear contractual terms to manage cost volatility. Institutions adapted by revising contractual risk allocations and by establishing inventory buffers for time-sensitive reagents. Additionally, the heightened cost visibility prompted innovation in resource utilization, such as optimizing storage formats and improving volume reduction techniques to reduce consumable consumption per specimen.

From a strategic perspective, the tariff environment catalyzed stronger emphasis on supply chain transparency and resilience. Organizations that had previously underinvested in supplier qualification and contingency planning found themselves revisiting those priorities. Conversely, those that leveraged strategic procurement, long-term supplier agreements, and incremental investments in domestic capabilities minimized disruption and maintained continuity of clinical and research activities.

Deep segmentation analysis revealing distinct requirements across banking models, service offerings, clinical applications, and end-user expectations that drive strategic differentiation

When evaluating the market through the lens of banking model, a clear dichotomy emerges between providers focused on individualized custodial services and those oriented toward public availability and transplantation support. Private banks tend to invest in consumer-facing education, long-term customer retention, and value propositions tied to family-directed access, while public banks prioritize donor recruitment, matching systems, and integration with national transplant networks.

Examining offerings reveals discrete operational domains: collection processes that ensure sterile, timely retrieval at birth; processing functions that include cell separation, viability testing, and volume reduction to prepare units for cryostorage; release procedures that govern clinical dispatch for transplantation or research; and long-term storage systems that maintain sample integrity under rigorous traceability and temperature control. Innovations in any of these stages can materially affect downstream usability and cost structures.

Application-based segmentation highlights clinical and scientific priorities. Blood disorders such as anemia, leukemia, and lymphoma remain core therapeutic targets for cord blood transplantation, while immune disorders and metabolic conditions continue to drive research interest. Regenerative medicine and research applications expand the potential utility of stored units, requiring additional data on potency and longer-term outcomes to support wider adoption.

Finally, end users-including diagnostic laboratories, hospitals and clinics, and research institutes-engage with banks under different time horizons and quality expectations. Diagnostic laboratories often require validated sample processing and strict chain-of-custody documentation, whereas hospitals and clinics demand operational excellence at the point of collection and seamless clinical integration. Research institutes prioritize accessibility and standardized metadata to enable reproducible studies. Understanding these nuanced needs across segmentation axes informs tailored service design and contract structures.

Regional dynamics and regulatory nuances across the Americas, Europe-Middle East-Africa, and Asia-Pacific that determine investment priorities and strategic partnerships

Regional dynamics exert powerful influence on regulatory frameworks, payer attitudes, and the maturity of cord blood banking ecosystems. In the Americas, established private banking networks coexist with public registries, and clinical centers maintain strong transplantation experience that supports sustained demand for high-quality units. Regional regulatory bodies have incrementally updated guidance to accommodate cell therapies, and commercial players often emphasize consumer engagement and product differentiation.

In Europe, the Middle East & Africa region, regulatory harmonization efforts and national tissue directives shape operational requirements. Public banking infrastructure and national registries play a prominent role in certain countries, while cross-border cooperation supports transplantation matching. Regulatory nuance across jurisdictions requires banks to invest in multi-jurisdictional compliance programs and localized clinical partnerships to ensure access to varied patient populations.

Across the Asia-Pacific region, rapid adoption of novel therapies and investment in biotechnology infrastructure drive demand for both private and public banking services. Growth in clinical trials and translational research has created opportunities for collaborative models between banks and therapeutic developers. However, heterogeneity in regulatory maturity and varying reimbursement landscapes necessitate localized strategies that account for cultural, clinical, and policy differences. These regional distinctions inform where to prioritize investments in infrastructure, clinical outreach, and compliance capabilities.

Competitive landscape assessment showing how alliances, technological differentiation, and consolidation are redefining company strategies and value creation pathways

Competitive dynamics in the cord blood banking sector reflect a mix of legacy custodial providers, vertically integrated clinical service organizations, and nimble startups that commercialize novel processing and analytics technologies. Established custodial providers typically leverage scale in collection networks, customer relationships, and long-term storage operations, while newer entrants often focus on differentiated laboratory capabilities, proprietary viability assays, or partnerships with therapeutic developers.

Strategic alliances between banks and biotechnology companies have become increasingly prevalent as developers seek reliable, high-quality source material for clinical programs. These alliances frequently include co-investment in processing protocols, validation studies, and data sharing agreements that accelerate translational timelines. Similarly, technology vendors supplying automated processing platforms and advanced cryogenic hardware have created opportunities for banks to raise quality standards and reduce per-unit variability.

Mergers and acquisitions continue to influence the competitive landscape, with consolidation enabling scale economies in storage and compliance while also driving integration of clinical and research services. At the same time, institutional investors and healthcare systems are exploring joint ventures and captive banking solutions to secure access to qualified donor material for internal therapeutic pipelines. In aggregate, these company-level strategies reflect a market where differentiation increasingly rests on evidence generation, supply chain reliability, and the capacity to support clinical development partners.

Actionable strategic priorities for leaders focused on clinical evidence generation, operational resilience, strategic partnerships, and customer engagement to secure long-term value

Industry leaders should prioritize a balanced approach that strengthens clinical credibility while building operational resilience. First, invest in evidence generation through prospective registries and clinician partnerships to substantiate clinical utility across target indications. Align these efforts with robust quality systems and transparent documentation to ease regulatory interactions and support payer conversations.

Second, enhance supply chain resilience by diversifying vendors for critical equipment and consumables, negotiating multi-year agreements where feasible, and exploring regional manufacturing or procurement hubs to mitigate tariff-driven volatility. Simultaneously, adopt laboratory automation and standardized viability testing to reduce operational variability and improve unit usability for translational programs.

Third, pursue strategic collaborations with therapeutic developers and research institutes. Co-development agreements and material access arrangements can create new revenue streams and accelerate the clinical validation of cord blood-derived applications. Finally, strengthen customer-facing capabilities through clearer education, post-storage engagement, and digital portals that simplify long-term custody decisions and enable lifecycle monetization opportunities. Taken together, these actions will position organizations to capture clinical opportunities while managing regulatory and commercial risk.

Robust mixed-methods research framework combining expert interviews, regulatory review, and data triangulation to underpin evidence-based strategic recommendations

This research synthesizes primary stakeholder interviews, regulatory and clinical literature review, and observational analysis of operational practices to construct evidence-based conclusions. Primary engagement included structured conversations with laboratory directors, transplant clinicians, procurement specialists, and regulatory affairs professionals to capture practical challenges and evolving expectations. These interviews were complemented by careful review of guidance documents, clinical trial registries, and peer-reviewed studies that document procedural innovations and therapeutic outcomes.

Secondary research incorporated industry publications, technology vendor specifications, and publicly available policy updates to contextualize operational trends within broader trade and regulatory developments. Data triangulation ensured consistency across sources, with discrepant findings subjected to follow-up inquiries or cross-verification through alternate data channels. Quality assurance processes included expert peer review and scenario analysis to identify plausible responses to policy shifts and technological adoption curves.

Methodologically, the study emphasized qualitative depth over speculative quantitative projections. That emphasis enables readers to understand causal relationships, operational levers, and the pragmatic steps required to translate scientific promise into dependable services. Transparency in source attribution and methodological limitations accompanies all major assertions to support confident decision-making.

Conclusion summarizing how quality, strategic partnerships, and supply chain resilience determine which organizations will lead the next phase of therapeutic and clinical adoption

The convergence of scientific advances, operational standardization, and geopolitical pressures is reshaping the cord blood banking ecosystem in meaningful ways. Clinical opportunity now coexists with increased expectations for traceability, quality, and collaborative evidence generation. At the same time, supply chain disruptions and tariff dynamics have highlighted the importance of procurement agility and regional capacity building.

Organizations that align laboratory excellence with proactive regulatory engagement and strategic partnerships will secure competitive advantage. Investing in validated processing protocols, automated viability testing, and durable clinical relationships creates a foundation for long-term relevance. Conversely, those that delay integrating new technologies or fail to shore up supply chain resilience risk operational discontinuities and diminished clinical credibility.

In closing, the sector's trajectory favors actors who view cord blood banking not merely as a custodial service, but as an integral partner in translational science. By emphasizing quality, collaboration, and adaptability, leaders can unlock broader clinical applications while safeguarding the integrity of stored biological assets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of advanced cryopreservation technologies to improve viability and longevity of stored cord blood stem cells
  • 5.2. Increasing integration of AI and blockchain for enhanced traceability and transparency in cord blood storage and usage
  • 5.3. Emergence of personalized medicine driving demand for HLA-typed cord blood units for targeted immunotherapies
  • 5.4. Expansion of public-private hybrid cord blood banks to increase accessibility in emerging economies
  • 5.5. Rising investments in research on ex vivo expansion of hematopoietic stem cells from cord blood for broader clinical applications
  • 5.6. Regulatory harmonization efforts shaping international standards for quality and safety in cord blood banking services
  • 5.7. Collaboration between biotech firms and cord blood banks to commercialize novel cell therapy products using neonatal stem cells
  • 5.8. Consumer-focused marketing campaigns emphasizing future therapeutic potentials of autologous cord blood storage
  • 5.9. Adoption of minimally invasive collection kits designed for home-based cord blood harvesting by expectant parents
  • 5.10. Implementation of cost-effective modular storage solutions reducing operational expenses for cord blood banks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Umbilical Cord Blood Banking Market, by Banking Model

  • 8.1. Private
  • 8.2. Public

9. Umbilical Cord Blood Banking Market, by Offerings

  • 9.1. Collection
  • 9.2. Processing
    • 9.2.1. Cell Separation
    • 9.2.2. Viability Testing
    • 9.2.3. Volume Reduction
  • 9.3. Release
  • 9.4. Storage

10. Umbilical Cord Blood Banking Market, by Application

  • 10.1. Blood Disorders
    • 10.1.1. Anemia
    • 10.1.2. Leukemia
    • 10.1.3. Lymphoma
  • 10.2. Immune Disorders
  • 10.3. Metabolic Disorders
  • 10.4. Regenerative Medicine
  • 10.5. Research

11. Umbilical Cord Blood Banking Market, by End User

  • 11.1. Diagnostic Laboratories
  • 11.2. Hospitals And Clinics
  • 11.3. Research Institutes

12. Umbilical Cord Blood Banking Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Umbilical Cord Blood Banking Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Umbilical Cord Blood Banking Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Cord Blood Registry, LLC
    • 15.3.2. Cryo-Cell International, Inc.
    • 15.3.3. ViaCord, LLC
    • 15.3.4. StemCyte, Inc.
    • 15.3.5. Macopharma S.A.
    • 15.3.6. Stemlife Berhad
    • 15.3.7. Cell Care Pty Ltd
    • 15.3.8. LifeCell International Private Limited
    • 15.3.9. Smart Cells International
    • 15.3.10. ViaCord

LIST OF FIGURES

  • FIGURE 1. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. UMBILICAL CORD BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. UMBILICAL CORD BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UMBILICAL CORD BLOOD BANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY CELL SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VIABILITY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY VOLUME REDUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RELEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY ANEMIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 270. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 271. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 272. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 273. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 274. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 275. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 278. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 279. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. GCC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPEAN UNION UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BANKING MODEL, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY OFFERINGS, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 303. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2018-2024 (USD MILLION)
  • TABLE 306. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BLOOD DISORDERS, 2025-2032 (USD MILLION)
  • TABLE 307. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. BRICS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)

TABLE